Medicare Enrolled
Dr. Sabrina Rene, M.D.
Endocrinology · Newnan, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rene from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rene?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rene
Dr. Sabrina Rene is an endocrinology specialist in Newnan, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rene performed 1,071 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rene received a total of $30,050 from 64 pharmaceutical and/or device companies across 713 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rene is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 47% volume in GA
$30,050 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,071
Medicare services
Top 47% in GA for endocrinology
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $81 | $370 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
181 | $3 | $11 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
119 | $15 | $78 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
93 | $25 | $123 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $112 | $496 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
48 | $9 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $104 | $561 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$30,050
Total received (2018-2024)
Avg $4,293/year across 7 years
Top 13% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
713
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,044
2023
$2,066
2022
$1,628
2021
$3,772
2020
$6,018
2019
$4,776
2018
$9,746
Payments by company (2024)
Novo Nordisk Inc
$323
Lilly USA, LLC
$234
Abbott Laboratories
$192
Xeris Pharmaceuticals, Inc.
$192
SANOFI-AVENTIS U.S. LLC
$157
Radius Health, Inc.
$115
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Tandem Diabetes Care, Inc.
$90
Corcept Therapeutics
$81
Medtronic, Inc.
$71
ABBVIE INC.
$57
BETA BIONICS, INC.
$49
Esperion Therapeutics, Inc.
$48
Amgen Inc.
$47
Dexcom, Inc.
$46
IBSA Pharma Inc.
$35
Nevro Corp.
$33
Kyowa Kirin, Inc.
$29
Madrigal Pharmaceuticals
$25
Insulet Corporation
$25
Eton Pharmaceuticals, Inc.
$22
CeQur Corporation
$22
SHIELD THERAPEUTICS INC
$22
Alexion Pharmaceuticals, Inc.
$19
Ascendis Pharma Inc
$14
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,055
AbbVie Inc.
$4,993
AbbVie, Inc.
$4,590
Tandem Diabetes Care, Inc.
$2,561
Lilly USA, LLC
$1,971
Novo Nordisk Inc
$1,542
Insulet Corporation
$951
Abbott Laboratories
$946
SANOFI-AVENTIS U.S. LLC
$670
IBSA Pharma Inc.
$597
Xeris Pharmaceuticals, Inc.
$562
Amgen Inc.
$510
Corcept Therapeutics
$496
Radius Health, Inc.
$488
Amarin Pharma Inc.
$303
Dexcom, Inc.
$206
Merck Sharp & Dohme Corporation
$190
Esperion Therapeutics, Inc.
$189
Medtronic, Inc.
$188
Astellas Pharma US Inc
$151
ABBVIE INC.
$150
Alexion Pharmaceuticals, Inc.
$145
Amneal Pharmaceuticals LLC
$125
PFIZER INC.
$84
MannKind Corporation
$79
Bayer HealthCare Pharmaceuticals Inc.
$79
Embecta Corp.
$78
Medtronic MiniMed, Inc.
$64
Becton, Dickinson and Company
$60
RECORDATI_RARE_DISEASES_INC.
$58
Ultragenyx Pharmaceutical Inc.
$56
AstraZeneca Pharmaceuticals LP
$53
Nevro Corp.
$51
BETA BIONICS, INC.
$49
Companion Medical, Inc.
$47
ARBOR PHARMACEUTICALS, INC.
$45
Shire North American Group Inc
$44
Janssen Pharmaceuticals, Inc
$41
Ferring Pharmaceuticals Inc.
$36
Ascendis Pharma Inc
$35
Azurity Pharmaceuticals, Inc.
$34
Antares Pharma, Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Kyowa Kirin, Inc.
$29
Arbor Pharmaceuticals, Inc.
$29
Mannkind Corporation
$28
Madrigal Pharmaceuticals
$25
GRT US Holding, Inc.
$25
EUSA Pharma (US) LLC
$24
Amryt Pharma Holdings Ltd
$24
Eton Pharmaceuticals, Inc.
$22
CeQur Corporation
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
SHIELD THERAPEUTICS INC
$22
DEXCOM, INC.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$17
Taiho Oncology, Inc.
$17
Merck Sharp & Dohme LLC
$15
Senseonics, Incorporated
$14
Supernus Pharmaceuticals, Inc.
$14
Tolmar, Inc.
$13
Acerus Pharmaceuticals Corporation
$12
E.R. Squibb & Sons, L.L.C.
$12
Gemini Laboratories, LLC
$11
Top 3 companies account for 52.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · ALKINDI · Androgel · BAQSIMI · BD 6cess · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CYCLOSET · CeQur Simplicity · Creon · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · EVENITY · EVUSHELD · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Gliadel · Guardian Connect · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · KEYTRUDA · Kerendia · Korlym · LICART · LUPRON DEPOT · LYUMJEV · Lonsurf · Lupron Depot · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NEXLETOL · NOCDURNA · Natesto · Norditropin · OPDIVO · Omnia · Omnipod · Ozempic · PROCLAIM · Prolia · Qutenza · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Skytrofa · Strensiq · Sylvant · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Triptodur · Tymlos · UNITHROID · Vascepa · Veozah · Wegovy · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
10
County median income
$94,142
Nearest hospital to ZIP centroid (approximate)
PIEDMONT NEWNAN HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rene is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rene experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rene performed 522 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rene receive payments from pharmaceutical companies?
Yes. Dr. Rene received a total of $30,050 from 64 companies across 713 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rene's costs compare to other endocrinologists in Newnan?
Dr. Rene's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rene) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Newnan
Browse endocrinologists in Newnan ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology